[Interactions of statins with antithrombotic drugs].
D000818:Animals; D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001241:Aspirin / Q000008:administration & dosage / Q000494:pharmacology*; D000069059:Atorvastatin; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D000077144:Clopidogrel; D018849:Controlled Clinical Trials as Topic; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D005500:Follow-Up Studies; D006487:Hemostasis / Q000187:drug effects; D006538:Heptanoic Acids / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D017035:Pravastatin / Q000008:administration & dosage / Q000494:pharmacology; D011322:Primary Prevention; D011758:Pyrroles / Q000008:administration & dosage / Q000494:pharmacology; D051381:Rats; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology*; D013997:Time Factors
D000924:Anticholesteremic Agents; D005343:Fibrinolytic Agents; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin; D000077144:Clopidogrel; D017035:Pravastatin; D013988:Ticlopidine; D001241:Aspirin
Beeinflussen Statine die Effekte antithrombotischer Pharmaka?